Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

GINA KOLATA
Author: GINA KOLATA

Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.